SEARCH:   Advanced		CURRENT ISSUE+more issues CME Credit Now Available Monthly 26 Aug 2010 Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management CME Article: Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan Total Therapy 3 for multiple myeloma: prognostic implications of cumulative dosing and premature discontinuation of VTD maintenance components, bortezomib, thalidomide, and dexamethasone, relevant to all phases of therapy Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency? e-LETTERS Most recent Individual drug dose-intensity and outcome in myeloma Experience is everything: rates of transplantation and leukemia-free survival Re: Do chromosomal abnormalities show up during mesenchymal stromal cell expansion? Read more How to submit an e-Letter ANNOUNCEMENTS Blood now offers faster feedback through e-Letters Hematologists Can Now Earn CME Credits through Blood Blood Cited as One of the Top 100 Influential Biology and Medicine Journals ASH’s Alternative to NIH Policy on Public Access THREE MOST FREQUENTLY READ ARTICLES+more collections WHO-EORTC classification for cutaneous lymphomas May 15, 2005 How I treat patients with diffuse large B-cell lymphoma Jul 01, 2007 How I treat idiopathic thrombocytopenic purpura (ITP) Oct 01, 2005